SHARE
Topical Drug Delivery Market

Topical Drug Delivery - Global Market Outlook (2020-2028)

4.7 (50 reviews)
Published: April 2021 ID: SMRC20423
4.7 (50 reviews)
Published: April 2021 ID: SMRC20423

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Topical Drug Delivery Market is accounted for $96.99 billion in 2020 and is expected to reach $184.92 billion by 2028 growing at a CAGR of 8.4% during the forecast period. Increasing incidences of skin infections, growing prevalence of diabetes and rising incidences of eye diseases are driving the market growth. However, preference for alternative modes of drug delivery and product recalls due to drug failure are hampering the growth of the market.

Topical drug delivery is a drug substance used more specifically to an affected site, without any change in drug levels, offers better compliance, and it is highly suitable for self-medication. Topical drug delivery is one of the most effective ways of drug delivery owning to its optimum therapeutic results. The delivery of drug substance is easy through skin, as skin provides a perfect site for local as well as systemic results.

Based on the product, the semi-solid formulations segment is going to have lucrative growth during the forecast period as semisolids are the most popular formulations and easy application of semi-solid formulations and their ability to deliver a wide variety of drug molecules is resulting in a stable demand for this segment among end users. By geography, Asia Pacific is going to have high growth during the forecast period owing to the high incidence of skin diseases (such as skin cancer), increasing use of contraceptives, and the growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems.

Some of the key players profiled in the Topical Drug Delivery Market include Teligent, Inc., Akorn Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Perrigo, Novartis, Allergan, Inc., Mylan, Bayer, LEO Pharma, Taro Pharmaceutical Industries Ltd., Ingenus Pharmaceuticals, Hisamitsu Pharmaceutical Co., Inc., Glenmark Pharmaceuticals, Crescita Therapeutics, Encore Dermatology, Crown Laboratories, GlaxoSmithKline, Cipla, Biofrontera, Johnson & Johnson, Bausch Health, Almirall, Merck & Co. and Aclaris Therapeutics.  

Products Covered:
• Liquid Formulations
• Solid Formulations
• Semi-Solid Formulations
• Transdermal Products

Route of Administrations Covered:
• Vaginal Drug Delivery 
• Rectal Drug Delivery 
• Ophthalmic Drug Delivery 
• Nasal Drug Delivery 
• Dermal/Skin Drug Delivery     

Devices Covered:
• Inhaler
• Patch 

Types Covered:
• Soft & Elastic Braces and Supports
• Hard & Rigid Braces and Supports
• Hinged Braces and Supports

Facility of Uses Covered:
• Home Care Settings
• Hospitals and Private Clinics
• Burn Centers
• Other Facilities 

Distribution Channels Covered:
• Direct Tenders
• Retail

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials